Canada: Hypothetical World When Multiple S. 8 Damages Cases Held Not To Reflect Size Of Actual Generic Market (Intellectual Property Weekly Abstracts Bulletin - Week Of March 31)

Last Updated: April 4 2014
Most Read Contributor in Canada, September 2016

Edited by Chantal Saunders and Beverley Moore , Adrian Howard and Ryan Steeves

Hypothetical World When Multiple S. 8 Damages Cases Held Not to Reflect Size of Actual Generic Market

Apotex Inc. v. Sanofi-Aventis, 2014 FCA 68

Drug: ramipril

In May, 2012, the Federal Court quantified damages owed to Apotex pursuant to s. 8 of the NOC Regulations (decision here, summary here). Similarly, damages were quantified to Teva, as discussed in the case below. Both parties appealed. In a split decision, the Federal Court of Appeal (FCA) upheld the trial judge's findings with respect to all issues but the date upon which Teva would have entered the market.

The FCA considered Sanofi's arguments that  the combined effect of the decisions of the Trial Judge in this case and the Teva case below was that the hypothetical generic market exceeds the size of the actual generic market. However, the Court rejected this argument, holding that the Trial Judge was correct in her interpretation of the NOC Regulations. The NOC Regulations should only be disregarded with respect to the determination of the beginning of the liability period. All other dates must be determined on the basis that the NOC Regulations exist. As a result, the hypothetical worlds in different cases will not be the same. The FCA invited Parliament or the Governor-in-Council to remedy the NOC Regulations if this is a problem.

The FCA held that the generic parties would have behaved in the hypothetical world just as they did in the real world. This included seeking summary dismissal of NOC Proceedings as soon as they considered they had a fair chance of success. However, the Court saw no reason to conclude that this would have happened any earlier in the hypothetical world than it did in the real world. Thus, Teva would not have entered the market during Apotex' s. 8 liability period and the only competition to Apotex would have been the authorized generic.

Appeals Dismissed from Quantification of S. 8 Damages

TevaCanada Limited v. Sanofi-Aventis Canada Inc.,2014 FCA 67

Drug: ramipril

As discussed above, in May 2012, the Federal Court quantified damages owed to Apotex and Teva pursuant to s. 8 of the NOC Regulations. (Teva decision here, summary here). Both parties appealed, and the FCA dismissed both the appeal and the cross-appeal.

As above, the FCA concluded that the hypothetical world constructed for the purposes of determining s. 8 damages includes the NOC Regulations, except for the purpose of determining the beginning of the liability period. The FCA considered arguments from both sides regarding the date Apotex would have entered the market and dismissed them.

Appeal Upholds Dismissal of Request to Amend Pleadings due to Proximity to Trial

Sanofi-Aventis v. Apotex Inc., 2014 FCA 66

Drug: ramipril

This case concerns an appeal of a motion to amend pleadings in the s. 8 case described above. The motion had originally been brought three months prior to trial and dismissed due to their timing and the real risk of having to adjourn the trial. Sanofi sought to amend its pleadings to assert that a different generic company would have been the first to enter the hypothetical market. Sanofi also sought to amend its pleadings to argue that there should be no s. 8 damages for an unapproved indication. The appeals were dismissed for substantially the same reasons as in Sanofi v. Teva (summary here).

Appeal of the Re-Examination Board's Decision Dismissed: Three Claims Rejected

Newco Tank Corp. v. Attorney General of Canada, 2014 FC 287

This was an appeal of a decision of a Re-Examination Board cancelling three claims of Newco Tank Corp.'s ("Newco") Canadian Patent No. 2,421,384 (the " '384 Patent"). On appeal, Newco sought an order cancelling the Certificate of the Board confirming the patentability of the subject claims, or in the alternative, an order returning the '384 Patent to the Board for a new decision to redetermine the issue of obviousness.

The '384 Patent issued on December 15, 2009,  and on October 4, 2011, the Commissioner wrote to Newco to inform it that a re-examination of the '384 Patent had been requested. The requester had brought to the Board's attention 11 U.S. patents and asked that the subject claims be disallowed. The Board ultimately found that the subject claims were novel, but rejected them as being obvious in view of certain of the U.S. patents.

On appeal, the Court considered five (5) issues, including certain questions related to the test for obviousness: (1) Was the Board's selection of the POSITA reasonable? (2) Was the Board's identification of the POSITA's skill level reasonable? (3) Did the Board unreasonably base the decision on its perspective and not that of the POSITA? (4) Did the Board unreasonably conclude that the problem of inefficient heating formed part of the common general knowledge and prior art? and (5) Did the Board act unreasonably in applying the 'obvious to try' test?

With respect to the first two issues, the Court deferred to the Board's expertise and found that its decisions were reasonable. With respect to the third issue, the Court noted that this argument was "unfounded" and amounted to a "complaint about the wording chosen by the Board to express its reasons for decision". Reading the decision as  a whole, the Court concluded that the Board did not substitute its own perspective on the matter  for that of the notional skilled person, despite the Board's use of words such as "we see..." and "our opinion...". With respect to the fourth issue, Newco argued that the 'problem' statement (i.e. a solution to the inefficient heating method) was clearly presented as part of the invention rather than as part of the background; and as such, the Board based its rejection on an incorrect assumption that the 'inefficient method' was part of the prior art and common general knowledge. However, the Court concluded that it was reasonable for  the Board to consider the information found in the patent (i.e. under the "Summary of the Invention" heading) to be part of the background knowledge
which the skilled person would have. With respect to the final issue, the Court found that the 'obvious to try' test was neither required nor used by the Board.

The Court held that Newco failed to meet its burden of establishing that the Board's decision was unreasonable; the Court found "no palpable and overriding error". The appeal was dismissed with costs on the normal scale.

About BLG

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.